Back to top
more

Moderna (MRNA)

(Real Time Quote from BATS)

$129.12 USD

129.12
1,636,818

+3.45 (2.75%)

Updated May 14, 2024 12:14 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value F Growth C Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (92 out of 250)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Gilead Up as Remdesivir Shows Promise in Treating Coronavirus

by Zacks Equity Research

Gilead (GILD) leads the race of companies developing treatments for coronavirus with experimental candidate, remdesivir, showing promise.

Is Moderna (MRNA) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Is (MRNA) Outperforming Other Medical Stocks This Year?

Tirthankar Chakraborty headshot

4 Top Biotech Stocks to Buy in the Time of Coronavirus

by Tirthankar Chakraborty

We have picked biotech companies that are widely expected to develop a vaccine for the coronavirus and fight off the worst stock market carnage since the 2008 financial crisis.

The Zacks Analyst Blog Highlights: Netflix, Microsoft, Sempra Energy, Co-Diagnostics and Moderna

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Netflix, Microsoft, Sempra Energy, Co-Diagnostics and Moderna

Kaibalya Pravo Dey headshot

Coronavirus Vaccine Trial Begins, Biotech Competition Heats Up

by Kaibalya Pravo Dey

While the overall vaccine development process has been impressively fast so far, it might take 12-18 months to fully validate a potential vaccine.

Ekta Bagri headshot

Biotech Sector in Focus as Coronavirus Spreads Panic

by Ekta Bagri

The outbreak of COVID-19 has brought the volatile biotech sector under the spotlight as both large and small companies rush to develop treatments and vaccines to combat this pandemic.

Tirthankar Chakraborty headshot

5 Smart Ways to Profit From the Coronavirus Crisis

by Tirthankar Chakraborty

Even though majority of investors are in a state of shock, many know how to profit during uncertain times like these. Here're five ways you can put your money to work amid the coronavirus outbreak.

Sanghamitra Saha headshot

Beat Virus With 2 Sector ETFs & Stocks That Survived 2008 Crisis

by Sanghamitra Saha

These two sectors lost lesser than the broader market during the 2008 financial crisis and may help you to tide over the latest virus crisis.

Kinjel Shah headshot

3 Small Biotechs Provide Coronavirus Drug Development Updates

by Kinjel Shah

Several drug/biotech companies are working on making new antibodies, drugs, and vaccines to prevent and treat COVID-19.

Sreoshi Bera headshot

5 of the Best Coronavirus-Proof Stocks to Invest In Now

by Sreoshi Bera

With coronavirus cases on the rise, lack of labor and supply chain disruption are impacting businesses worldwide. However, certain industries could offer healthy returns on investment.

The Zacks Analyst Blog Highlights: Buckle, Chipotle Mexican Grill, Co-Diagnostics, Moderna and Regeneron Pharmaceuticals

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Buckle, Chipotle Mexican Grill, Co-Diagnostics, Moderna and Regeneron Pharmaceuticals

Tirthankar Chakraborty headshot

5 Stocks to Win Big From Trump's Economic Stimulus

by Tirthankar Chakraborty

Trump floats financial aids to counter the impact of the coronavirus outbreak. Notable stimulus measures include payroll tax cut, aid for wage earners and an emergency funding worth $8.3 billion

LabCorp (LH) Launches Test to Detect Presence of Coronavirus

by Zacks Equity Research

LabCorp (LH), with an aim to contain the outbreak of coronavirus, launches the LabCorp 2019 Novel Coronavirus (COVID-19), NAA test.

The Zacks Analyst Blog Highlights: Moderna, Inovio Pharmaceuticals, Vir Biotechnology and Alnylam Pharmaceuticals

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Moderna, Inovio Pharmaceuticals, Vir Biotechnology and Alnylam Pharmaceuticals

Regeneron (REGN) Gains from Focus on Coronavirus Treatments

by Zacks Equity Research

Regeneron's (REGN) shares grow year to date owing to focus on developing a treatment for combating the novel coronavirus.

Manaswita Ghosh Dutta headshot

House Okays $8 Billion Funds to Combat COVID-19: 3 Winners

by Manaswita Ghosh Dutta

U.S. lawmakers' deal to find a vaccine for tackling the coronavirus stands to benefit the healthcare industry.

Manaswita Ghosh Dutta headshot

3 Correction-Defying Bets to Buy as Markets Brave Coronavirus

by Manaswita Ghosh Dutta

Global markets lost $6 trillion in the week ended Feb 29 as coronavirus triggered sharp selloff. Here's how to play the dip.

5 Drug Makers to Gain From Coronavirus Outbreak

by Zacks Equity Research

Drug makers globally are working on developing therapies and vaccines for coronavirus. Here are five stocks that are currently in focus.

Tirthankar Chakraborty headshot

4 Top Stocks to Win Big From the Coronavirus Pandemic (Revised)

by Tirthankar Chakraborty

Professional money managers are looking to buy stocks that act as a hedge against coronavirus threat, or those that simply benefits from the particular event.

Kinjel Shah headshot

Trump Asks Pharma Firms to Step Up Coronavirus Vaccine Work

by Kinjel Shah

President Donald Trump asks pharmaceutical companies working on making vaccines or treatments for coronavirus to accelerate development.

Tirthankar Chakraborty headshot

Best & Worst Performing Stocks in Coronavirus Outbreak

by Tirthankar Chakraborty

Here're the big winners and losers since the coronavirus outbreak brought the U.S. bull market to a standstill.

The Zacks Analyst Blog Highlights: Moderna, Inovio Pharmaceuticals, Co-Diagnostics and Apple

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Moderna, Inovio Pharmaceuticals, Co-Diagnostics and Apple

Is the Options Market Predicting a Spike in Moderna (MRNA) Stock?

by Zacks Equity Research

Investors need to pay close attention to Moderna (MRNA) stock based on the movements in the options market lately.

Kinjel Shah headshot

5 Biotechs That Escaped the Coronavirus Onslaught Last Week

by Kinjel Shah

Here we discuss 5 biotech stocks that outperformed the industry amid the U.S. market slump.

Tirthankar Chakraborty headshot

4 Top Stocks to Win Big From the Coronavirus Pandemic

by Tirthankar Chakraborty

Professional money managers are looking to buy stocks that act as a hedge against coronavirus threat, or those that simply benefits from the particular event.